Open access
1,705
Views
56
CrossRef citations to date
0
Altmetric
Pharmacological Aspects
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
Más allá del receptor de dopamina: nuevos blancos terapéuticos para tratar la esquizofrenia
Au-delà du récepteur dopaminergique: de nouvelles cibles thérapeutiques pour traiter la schizophrénie.
Joseph T. CoyleDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USACorrespondence[email protected]
, Darrick BaluDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
, Michael BenneyworthDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
, Alo BasuDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
& Alexander RosemanDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
Pages 359-382
|
Published online: 01 Apr 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.